ATE218365T1 - Stabilisierte mischung auf fibrinogenbasis - Google Patents

Stabilisierte mischung auf fibrinogenbasis

Info

Publication number
ATE218365T1
ATE218365T1 AT98904163T AT98904163T ATE218365T1 AT E218365 T1 ATE218365 T1 AT E218365T1 AT 98904163 T AT98904163 T AT 98904163T AT 98904163 T AT98904163 T AT 98904163T AT E218365 T1 ATE218365 T1 AT E218365T1
Authority
AT
Austria
Prior art keywords
solution
fibrinogen
stabilized
based mixture
arginine
Prior art date
Application number
AT98904163T
Other languages
English (en)
Inventor
Israel Nur
Lilliana Bar
Oded Lieberman
Original Assignee
Omrix Biopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP97101569A external-priority patent/EP0856317A1/de
Application filed by Omrix Biopharm Sa filed Critical Omrix Biopharm Sa
Application granted granted Critical
Publication of ATE218365T1 publication Critical patent/ATE218365T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
AT98904163T 1997-01-31 1998-01-30 Stabilisierte mischung auf fibrinogenbasis ATE218365T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97101569A EP0856317A1 (de) 1997-01-31 1997-01-31 Fibrinogen enthaltende stabilisierte Mischung
PCT/EP1998/000502 WO1998033533A1 (en) 1997-01-31 1998-01-30 A stabilized mixture comprising fibrinogen

Publications (1)

Publication Number Publication Date
ATE218365T1 true ATE218365T1 (de) 2002-06-15

Family

ID=8226433

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98904163T ATE218365T1 (de) 1997-01-31 1998-01-30 Stabilisierte mischung auf fibrinogenbasis

Country Status (13)

Country Link
US (1) US6121232A (de)
JP (1) JP3825055B2 (de)
KR (1) KR100345570B1 (de)
CN (1) CN1182879C (de)
AT (1) ATE218365T1 (de)
AU (1) AU724715B2 (de)
BR (1) BR9807043A (de)
CA (1) CA2279419A1 (de)
DE (1) DE69805772T2 (de)
ES (1) ES2178153T3 (de)
HU (1) HUP0000908A3 (de)
NO (1) NO993709L (de)
PL (1) PL194316B1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7276235B2 (en) * 1998-11-18 2007-10-02 Zlb Behring Gmbh Tissue glue with improved antiadhesive properties
DE10025001A1 (de) * 2000-05-22 2001-11-29 Aventis Behring Gmbh Gewebekleber mit verbesserten anti-adhäsiven Eigenschaften
CN100345591C (zh) * 2003-08-01 2007-10-31 上海新兴医药股份有限公司 耐干热处理的速溶冻干纤维蛋白原制剂
US7186684B2 (en) * 2003-08-07 2007-03-06 Ethicon, Inc. Hemostatic device containing a protein precipitate
PL1809342T3 (pl) * 2004-10-20 2015-12-31 Ethicon Inc Wchłanialny hemostat
US9358318B2 (en) * 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
FR2887883B1 (fr) * 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
CN101678086B (zh) * 2007-03-22 2013-07-10 财团法人化学及血清疗法研究所 固体纤维蛋白原制剂
EP2011524A1 (de) * 2007-07-02 2009-01-07 Omrix Biopharmaceuticals Ltd. Fibrinleim mit Visualisierungsmittel
EP2034010A1 (de) * 2007-08-30 2009-03-11 Omrix Biopharmaceuticals Ltd. Zusammensetzungen zur Reparatur und/oder Behandlung von verletztem Rückenmarksgewebe
WO2010032246A2 (en) * 2008-09-22 2010-03-25 Omrix Biopharmaceuticals Ltd. Implantable device comprising a substrate pre-coated with stabilized fibrin
JP5805542B2 (ja) 2009-02-20 2015-11-04 オムリックス・バイオファーマシューティカルズ・リミテッドＯｍｒｉｘ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ． 少なくとも２成分の薬物を投与する装置
BR112012018970B1 (pt) 2010-01-28 2018-10-30 Omrix Biopharmaceuticals Ltd produto compreendendo fibrinogênio, thrombina e formulação de selante de fibrina líquida, método para preparação do mesmo e kit
IL207586A0 (en) 2010-08-12 2010-12-30 Omrix Biopharmaceuticals Ltd A fibrin based therapeutic preparation and use thereof
AU2011303467C1 (en) * 2010-09-15 2017-03-09 Debiopharm International Sa Method for separating target molecules or particles from fibrinogen-containing samples including blood components
ES2951828T3 (es) 2010-09-23 2023-10-25 Leading Biosciences Inc Administración de inhibidores de serina proteasa al estómago
IL210162A0 (en) 2010-12-21 2011-03-31 Omrix Biopharmaceuticals Viral inactivated platelet extract, use and preparation thereof
IL213375A0 (en) 2011-06-05 2011-07-31 Omrix Biopharmaceuticals Device for spraying fluids in proximity to a surface
US20150064141A1 (en) 2012-04-05 2015-03-05 The Regents Of The University Of California Regenerative sera cells and mesenchymal stem cells
US10130346B2 (en) 2012-07-24 2018-11-20 Omrix Biopharmaceuticals Ltd. Device and method for the application of a curable fluid composition to a bodily organ
CA2895652C (en) 2012-12-20 2020-10-27 Omrix Biopharmaceuticals Ltd. Viral inactivated biological mixture
US10849605B2 (en) 2012-12-30 2020-12-01 Omrix Biopharmaceuticals, Ltd. Device and method for the application of a curable fluid composition to a portion of a bodily organ
USD754325S1 (en) 2013-06-06 2016-04-19 Omrix Biopharmaceuticals Ltd. Device of a curable fluid composition to a bodily organ
IL230150A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing zymogens
IL230151A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing a polymerization inhibitor
KR102397379B1 (ko) 2014-03-25 2022-05-13 리딩 바이오사이언시즈, 인크. 자가소화의 치료용의 조성물
IL231792A0 (en) 2014-03-27 2014-08-31 Omrix Biopharmaceuticals Ltd Device and method for the preparation and administration of one-component fibrin glue
IL234246A0 (en) 2014-08-21 2014-11-30 Omrix Biopharmaceuticals Ltd Stabilized thrombin
IL235751A0 (en) 2014-11-18 2015-02-26 Omrix Biopharmaceuticals Ltd An addition to the spray dryer
WO2016079727A1 (en) 2014-11-18 2016-05-26 Omrix Biopharmaceuticals Ltd. Spray-drying apparatus and method of use
BR112017017628A2 (pt) 2015-02-25 2018-05-08 Omrix Biopharmaceuticals Ltd. método para a purificação e quantificação de trombina e seus polipeptídeos de degradação
IL242984A0 (en) 2015-12-08 2016-02-29 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, their preparation and how to use them
US10159720B2 (en) 2015-12-08 2018-12-25 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, preparation and uses thereof
IL242924A0 (en) 2015-12-03 2016-04-21 Omrix Biopharmaceuticals Ltd Syringe system for storing and mixing two ingredients
CN113908282A (zh) 2016-01-11 2022-01-11 恒翼生物医药科技(上海)有限公司 用于治疗和预防粘连及肠梗阻的组合物和方法
JP2017177073A (ja) * 2016-03-31 2017-10-05 テルモ株式会社 塗布具
IL247821A0 (en) 2016-09-14 2017-01-31 Omrix Biopharmaceuticals Ltd Adhesive preparations and their use
CN109081789B (zh) * 2017-06-13 2021-01-01 首都医科大学 氨基正己酰氨基甲环酰氨基正己酰脂肪氨基酸，其合成，活性和应用
IL261190A (en) 2018-08-16 2019-01-31 Omrix Biopharmaceuticals Ltd Stable liquid preparations of thrombin
IL263679A (en) 2018-12-12 2019-03-31 Omrix Biopharmaceuticals Ltd Kits, methods, and ingredients for preventing tissue adhesion
WO2020121289A1 (en) 2018-12-12 2020-06-18 Omrix Biopharmaceuticals Ltd. Low concentrated protein compositions for preventing tissue adhesion
JP2024534444A (ja) 2021-09-16 2024-09-20 エシコン・インコーポレイテッド 組織経路封止用組成物のためのキット
EP4452233A1 (de) 2021-12-21 2024-10-30 Omrix Biopharmaceuticals Ltd. Hochlösliche fibrinogenzusammensetzungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
DK475386D0 (da) * 1986-10-03 1986-10-03 Weis Fogh Ulla Sivertsen Fremgangsmaade og apparat til fremstilling af biologiske stoffer
US5278189A (en) * 1990-06-04 1994-01-11 Rath Matthias W Prevention and treatment of occlusive cardiovascular disease with ascorbate and substances that inhibit the binding of lipoprotein (A)
JPH08512215A (ja) * 1993-03-30 1996-12-24 オパーバス・ホールディング・ビー・ブイ 二成分フィブリングルー

Also Published As

Publication number Publication date
DE69805772T2 (de) 2003-01-30
ES2178153T3 (es) 2002-12-16
AU724715B2 (en) 2000-09-28
PL194316B1 (pl) 2007-05-31
JP2000509630A (ja) 2000-08-02
AU6214598A (en) 1998-08-25
KR20000070634A (ko) 2000-11-25
NO993709D0 (no) 1999-07-30
BR9807043A (pt) 2000-03-28
CN1246069A (zh) 2000-03-01
HUP0000908A2 (hu) 2000-08-28
KR100345570B1 (ko) 2002-07-26
JP3825055B2 (ja) 2006-09-20
CA2279419A1 (en) 1998-08-06
US6121232A (en) 2000-09-19
PL334547A1 (en) 2000-03-13
CN1182879C (zh) 2005-01-05
NO993709L (no) 1999-09-28
DE69805772D1 (de) 2002-07-11
HUP0000908A3 (en) 2001-05-28

Similar Documents

Publication Publication Date Title
ATE218365T1 (de) Stabilisierte mischung auf fibrinogenbasis
ATE111360T1 (de) Chirurgisches klebstoffmaterial.
ATE133449T1 (de) Infektiöses system zur arzneimittelabgabe
DE69230670D1 (de) Zusammensetzungen, die eine blutgerinnselpolymermatrix zur verabreichung von osteogenen proteinen enthalten
ATE74519T1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
TR199800046A2 (xx) Aktif maddeler yarat�lmas� i�in n�kleik asit olu�umu.
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
ES2163511T3 (es) Preparacion farmaceutica conteniendo glucagon.
ES2179910T3 (es) Modificacion cristalina del cdch, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
JPS6485096A (en) Hybrid human protein c and biotechnological synthesis thereof
DK1124589T3 (da) Formulering af fibrin-vævsklæber og fremgangsmåde til fremstilling af denne
ES2139740T3 (es) Cola de fibrina de dos componentes.
ATE380202T1 (de) Interaktionssystem zur präsentation und entfernung von substanzen
TW337997B (en) Pharmaceutical preparation containing plasminogen activators
BR9800913A (pt) Promotor de gene cdc25b, preparação e uso do mesmo.
TR199903192T2 (xx) Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar.
AU569896B2 (en) Process for the dissolution of peptides and proteins
ES2170747T3 (es) Analogos superiores de trombomodulina para uso farmaceutico.
DE69528170D1 (de) Intrazelluläre verabreichung therapeutischer sustanzenmittels virosomen
ATE131492T1 (de) Synthetische peptide und deren mischungen für den nachweis von hiv-antikörpern
ATE305612T1 (de) Reporterverbindungen und verfahren zur auffindung von hochspezifische proteaseaktivität
BR9811954A (pt) ácidos 3-aril-succinamido-hidroxâmicos, processos para sua produção e preparações farmacêuticas contendo estas substâncias
DE3889519D1 (de) Glutaminhaltige Peptide, Verfahren zu deren Herstellung und Verwendung.
DE69010518D1 (de) Wässerige Desmopressin-CMC enthaltende Arzneizubereitung.
DE50011068D1 (de) Fragmente des virus proteins 2 oder 3 des polyomavirus als fähren für wirkstoffe

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification